‘Prostate Screening Saved My Life’—Is That Really True in Most Cases?
By DEREK RAGHAVAN, MD, PhD, FACP, FASCO, FRACP
April 25, 2026
1. PSA screening remains controversial in prostate cancer management. 2. Critics question the demonstrated survival benefits. 3. PSA correlates with prostate disease but may misrepresent cancer extent. 4. Experts suggest a balanced approach to screening policies. 5. Increased communication and rational strategy is needed in clinical practice.